CrowdStrike (CRWD) is trading lower today (down about 5% to roughly $371.77) as traders revisit regulatory overhang tied to a federal investigation into a $32 million transaction routed through government reseller Carahsoft and connected to an IRS deal. The issue centers on questions around the structure and timing of the transaction and whether revenue recognition was appropriate, a headline that has periodically pressured the stock when it resurfaces. (bloomberg.com)

Regulatory scrutiny is especially impactful for premium-valued software names because it can introduce hard-to-model tail risks: potential changes to disclosures, internal-controls remediation, fines, or in a bearish scenario, restatement risk. Even without new financial impact, the uncertainty can compress the valuation multiple and keep some institutions sidelined. (disclosureinsight.com)

Key swing factors for CRWD over the next several sessions are any incremental updates on the DOJ/SEC review (including interview activity, document requests, or company commentary) and whether the move spreads into the broader cybersecurity group. Investors will also be watching for any new risk-factor language in filings and for management’s next opportunity to address the matter publicly. (investing.com)